ACTA1 and cancer: We investigated whether we could distinguish the two different subtypes of cancer-associated fibroblasts—anti-cancer (αSMA+/FAPα−) and pro-cancer (αSMA−/FAPα+) fibroblasts—by gene expression levels of αSMA and FAPα in bulk PDAC tumors.